The appearance of tumor or cancer is one of the worst experiences in people's lives. At this point, they must begin a hard path and undergo cancer therapies necessary with the sole aim of healing and being able to move on with their lives.
However, some of these people who have had some form of cancer and have managed to overcome it must face another concern:the infertility derived from cancer treatments.
Today, assisted reproduction and fertility preservation programs allow these affected people to fulfil their dream of becoming parents.
The different sections of this article have been assembled into the following table of contents.
Chemotherapy and radiation treatments to fight cancer can affect male and female fertility, causing both temporary and permanent infertility.
However, the risk of infertility and not being able to have a child naturally will depend on a number of factors:
The types of cancer that can most affect male fertility are testicular cancer, prostate cancer, leukemia, and Hodking's lymphoma.
In terms of female fertility, the most relevant types of cancer are breast cancer, cancer of the uterus or cervix, ovarian cancer and lymphomas.
That is why the American Society for Clinical Oncology (ASCO) recommends that all individuals who are initiating oncology treatment talk to a member of the medical care team about the effects on their fertility and whether there are fertility preservation options that are compatible with such treatments.
Chemotherapy aims to kill rapidly dividing cells in the body, such as tumour cells.
However, males have other cell types with rapid division: sperm. This makes both sperm and spermatogonies (testicular stem cells) easy targets for antitumor drugs.
On the other hand, the high-energy rays used in radiation therapy to destroy cancer cells can also affect these sperm-producing stem cells, especially if the radiation is directed at the testicles.
The type of infertility that men can suffer once the cancer is over, temporal or permanent, will depend on the damage caused to the spermatogonial stem cells of the testicles. If they are severely damaged, they will not be able to divide further and produce new sperm.
In addition, radiation therapy may also affect the brain, specifically the hypothalamus and pituitary gland, and alter the entire hormonal production that regulates spermatogenesis. This would also result in a drop in sperm production and sex hormones such as testosterone.
In women, the main consequence of oncological treatments is the decrease in ovarian reserve, especially in the case of radiotherapy in the pelvic area.
In these cases, age is a crucial factor. The younger a woman is, the more likely she is to keep a small part of her eggs after overcoming cancer.
However, it should be noted that all women who have received chemotherapy or radiation therapy are prone to premature ovarian failure or early menopause.
On the other hand, radiation directed at the uterus can also cause damage that prevents the embryo from being implanted in the endometrium or stretched during gestation, leading to miscarriages or premature babies.
As with men, cancer therapies can also affect the hypothalamus-pituitary-ovarian axis and cause menstrual cycles to maladjustment.
Many of the fertility alterations discussed throughout this article may have a solution if the person affected by the cancer makes the decision to preserve his or her fertility.
This is why it is essential to consult a specialist before receiving cancer treatment.
The options men have to preserve their fertility are discussed below:
If you are considering preserving your fertility to have a baby in the future, we recommend that you start by getting a Fertility Report. In 3 simple steps, it will show you a list of clinics that fit your preferences and meet our strict quality criteria. Moreover, you will receive a report via email with useful tips to visit a fertility clinic for the first time.
Regarding women there are various alternatives although some of them are more complicated or are currently in an experimental period.
The ovarian stimulation phase of fertility treatment is the most frightening for patients, especially if they have had hormone-dependent cancer.
However, it is always necessary to wait until enough time has passed so that no malignant cells can be detected in the body. At this point IVF could be performed.
Read more
Ovarian stimulation is the medical treatment used to obtain the patient's own eggs in the process of In Vitro Fertilisation (IVF). This process does not pose any "threat" to the ovary, but rather a recovery of its full potential.
There is no increased risk of cancer with ovarian stimulation treatment.
Read more
It has been known for years that cancer treatments damage the male and female germ line. Until recently, the priority in the face of cancer was to be cured. Due to the great advances achieved in the treatment of cancer and the high survival rates that are obtained today in some types of tumours, the importance of controlling the side effects of these treatments is gaining ground. One of them is infertility and, although men have been able to store sperm from the ejaculate for years, today women can also freeze eggs and ovarian tissue.
The approach must be prior to the start of chemotherapy or radiotherapy, otherwise it will be too late to do anything. Therefore, adequate information on the part of your oncologist is a matter of priority, as it will depend on the type of tumour, the type of oncological treatment to be used, the patient's age, the time available, etc.
Nowadays, men can freeze semen as they did years ago, with a very good chance of success if this semen is used in inseminations or in vitro fertilization.
Women can opt for two options: a) freezing of ovarian tissue, which requires surgery to remove part or all of the ovary, and freezing this tissue in small fragments, to be re-implanted once the cancer has been cured, or b) freezing of oocytes, which requires a period of 2 weeks to be able to carry out ovarian stimulation and remove the oocytes as is done in conventional in vitro fertilization, but with a very specific medication protocol to avoid harmful effects on hormone-dependent tumours.
There are indeed medical practice guides of scientific societies, where in a consensual way they try to establish the behaviors or offered treatments in those cases, and to inform objectively about the advantages and disadvantages, as well as what is not known about these issues. Specifically, and in Spain, the Spanish Fertility Society has a group that is working precisely on this consensus document.
If cancer is diagnosed once the woman is pregnant, the options will obviously depend on the type of tumor and the treatment needed (Surgery? Chemotherapy? Radiation therapy? Combinations?).
There are many cases treated, but it is true that in the first trimester of gestation there is a great risk of abortion and even malformations, and when it occurs in the third trimester, of premature birth, but in this case the collaboration of the multidisciplinary team that weighs the risks and benefits of the decision to take is fundamental.
Once cancer has been treated, the male may be fertile. If this is not the case, he may resort to using the sperm he had frozen before his treatment. In these cases, since the semen is very valuable because of its scarcity (only one or two frozen samples), ICSI is used directly, since gestation can be achieved with a single spermatozoon. Thus, if more children were desired, there would still be a frozen sample.
If you are interested in finding out more about how to preserve fertility in the face of cancer or other reasons, we recommend that you read on here: Fertility Preservation – Cost & Options for Retaining Your Fertility.
On the other hand, it is possible for cancer to appear during the gestation period, which has an increased risk for both mother and baby. You can read more about this here: Cancer during Pregnancy – What to Expect.
We make a great effort to provide you with the highest quality information.
🙏 Please share this article if you liked it. 💜💜 You help us continue!
ASCO Recommendations on Fertility Preservation in Cancer Patients: Guideline Summary. J Oncol Pract. 2006 May;2(3):143-146. doi: 10.1200/JOP.2006.2.3.143. PMID: 29443586; PMCID: PMC2794591. (View)
Barak S. Fertility preservation in male patients with cancer. Best Pract Res Clin Obstet Gynaecol. 2019 Feb;55:59-66. doi: 10.1016/j.bpobgyn.2018.12.004. Epub 2018 Dec 20. PMID: 30744950. (View)
Burns KC, Hoefgen H, Strine A, Dasgupta R. Fertility preservation options in pediatric and adolescent patients with cancer. Cancer. 2018 May 1;124(9):1867-1876. doi: 10.1002/cncr.31255. Epub 2018 Jan 25. PMID: 29370455. (View)
Del-Pozo-Lérida S, Salvador C, Martínez-Soler F, Tortosa A, Perucho M, Giménez-Bonafé P. Preservation of fertility in patients with cancer (Review). Oncol Rep. 2019 May;41(5):2607-2614. doi: 10.3892/or.2019.7063. Epub 2019 Mar 14. PMID: 30896846. (View)
Mahmood S, Drakeley A, Homburg R, Bambang K. Fertility Preservation in Female Patients with Cancer. Clin Oncol (R Coll Radiol). 2022 Aug;34(8):508-513. doi: 10.1016/j.clon.2022.03.021. Epub 2022 Apr 28. PMID: 35491364. (View)
Metzger ML, Meacham LR, Patterson B, Casillas JS, Constine LS, Hijiya N, Kenney LB, Leonard M, Lockart BA, Likes W, Green DM. Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications. J Clin Oncol. 2013 Mar 20;31(9):1239-47. doi: 10.1200/JCO.2012.43.5511. Epub 2013 Feb 4. PMID: 23382474; PMCID: PMC4500837. (View)
Rives N, Courbière B, Almont T, Kassab D, Berger C, Grynberg M, Papaxanthos A, Decanter C, Elefant E, Dhedin N, Barraud-Lange V, Béranger MC, Demoor-Goldschmidt C, Frédérique N, Bergère M, Gabrel L, Duperray M, Vermel C, Hoog-Labouret N, Pibarot M, Provansal M, Quéro L, Lejeune H, Methorst C, Saias J, Véronique-Baudin J, Giscard d'Estaing S, Farsi F, Poirot C, Huyghe É. What should be done in terms of fertility preservation for patients with cancer? The French 2021 guidelines. Eur J Cancer. 2022 Sep;173:146-166. doi: 10.1016/j.ejca.2022.05.013. Epub 2022 Aug 3. PMID: 35932626. (View)
Santos ML, Pais AS, Almeida Santos T. Fertility preservation in ovarian cancer patients. Gynecol Endocrinol. 2021 Jun;37(6):483-489. doi: 10.1080/09513590.2021.1872534. Epub 2021 Jan 27. PMID: 33501866. (View)
Ulrich ND, Raja NS, Moravek MB. A review of fertility preservation in patients with breast cancer. Best Pract Res Clin Obstet Gynaecol. 2022 Jun;82:60-68. doi: 10.1016/j.bpobgyn.2022.01.004. Epub 2022 Jan 15. PMID: 35120831. (View)